Success Metrics

Completion Rate

0%(0/1)

Active Trials

0(0%)

Terminated

1(33%)

Phase Distribution

Ph not_applicable

67%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Terminated(2)

Other(1)

Detailed Status

unknown1

Withdrawn1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (33.3%)

N/A2 (66.7%)

Trials by Status

unknown133%

withdrawn133%

terminated133%

Recent Activity

0 active trials

Showing 3 of 3

terminatednot_applicable

Atrial Pressure Electrophysiology Pilot Study

NCT01845974

withdrawnnot_applicable

Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation

NCT02344394

unknownphase_1

Renal Denervation in Patients With Uncontrolled Hypertension in Chinese

NCT01390831

Clinical Trials (3)

Showing 3 of 3 trials

NCT01845974Not Applicable

Atrial Pressure Electrophysiology Pilot Study

Terminated

NCT02344394Not Applicable

Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation

Withdrawn

NCT01390831Phase 1

Renal Denervation in Patients With Uncontrolled Hypertension in Chinese

Unknown

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3